Stocks

If you are having problems accessing, please clear your browser data (cache and cookies) for the last 4 weeks and try again. If you are still having problems, please contact us at +47 21 555 888.

Stocks

The table gives an overview of all stocks, alphabetically sorted.

Show advanced options

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Name	Symbol	Analysis date	Close	+/- %
Accentro Real Estate AG	A4Y	Apr 25, 2025	0.28	+300.00
Accenture plc Class A Ordinary Shares (Ireland)	CSA	Apr 25, 2025	255.90	+2.44
Accesso Technology Group Plc	LQG	Apr 25, 2025	4.96	+3.33
Acciona SA	AJ3	Apr 25, 2025	121.90	+8.26
Acco Brands Corporation	A3B	Apr 25, 2025	3.34	+5.70
Acconeer	2LU	Apr 25, 2025	0.46	+0.88
Accor	ACR1	Apr 25, 2025	8.50	+11.11
Accor SA	ACR	Apr 25, 2025	40.97	+5.32
Accsys Technologies	1D8	Apr 25, 2025	0.51	+0.20
Accuray Incorporated	XEJ	Apr 25, 2025	1.34	+5.51
Ace Hardware Indonesia TBK	4AH1	Apr 25, 2025	0.02	-7.50
ACE LIBERTY+STONE LS -,25	8MW	Apr 25, 2025	0.49	+0.41
ACEA SpA	DCA	Apr 25, 2025	19.52	+1.77
AcelRx Pharmaceuticals	R5XA	Apr 25, 2025	0.42	+14.27
Acer Incorporated	AC5G	Apr 25, 2025	4.00	+25.00
ACERINOX ADR 1/2/EO-,25	ACE	Apr 25, 2025	4.82	+3.43
Acerinox SA	ACE1	Apr 25, 2025	10.09	+4.72
Achieve Life Sciences, Inc. -	SP4P	Apr 25, 2025	2.08	+13.54
Achilles Therapeutics plc - American Depositary Shares	698	Apr 25, 2025	1.33	0.00
ACI Worldwide, Inc.	TSA	Apr 25, 2025	45.80	+1.33
ACINQUE S.P.A. EO 1	YA2	Apr 25, 2025	2.02	+1.00
Ackermans & van Haaren NV	B3K	Apr 25, 2025	210.20	+4.06
Aclara Resources Inc	JD1	Apr 25, 2025	0.43	+7.04
Aclaris Therapeutics, Inc.	8AT	Apr 25, 2025	1.11	+11.78
ACM Research, Inc. - Class A	813	Apr 25, 2025	18.38	+6.74
Acma Ltd	AAX1	Apr 25, 2025	0.01	+68.75
Acme United Corporation.	UT1	Apr 25, 2025	37.00	+5.71
Acom Co Ltd	AK5	Apr 25, 2025	2.38	+6.25
aconnic AG	CFC	Apr 25, 2025	0.95	+4.37
Acotec Scientific Holdings Limited	7W3	Apr 25, 2025	0.84	+11.18

Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.